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ABSTRACT

The oral cavity harbors more than 700 microbial species and is one of the most complex ecosystems ever described. While the majority of these microbes are considered commensal, some of them are responsible for oral infectious diseases such as dental caries, periodontitis, halitosis and stomatitis. The advancement of modern science has greatly furthered
our understanding of oral microbes and their roles in host health and disease. It has also led to
the development of new tools for early detection, effective treatment, and prevention of oral
microbial infections. This perspective provides a general understanding of oral microbiology,
and its clinical relationship to oral infectious diseases, with a specific focus on denture-related
microbial infections. The perspective also discusses the potential for developing innovative
interventions for managing denture-related disease based on recent advances in our understanding of oral microbiology and denture-associated biofilms.
KEYWORDS: Stomatitis; Oral microbiota; Candida albicans.
ABBREVIATIONS: SAP: Aspartyl proteinases; PL: Phospholipase; PDT: Photodynamic therapy;

STAMPs: Specifically Targeted Antimicrobial Peptides.
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The association between microbes and oral diseases had long been suspected. Dr. W.
D. Miller is generally recognized as the father of modern dental microbial pathogenesis. His
1890 seminal book titled Microorganisms of the Human Mouth1 makes the first connection
between bacteria in dental plaque and tooth decay, and remains a foundation of current understanding of dental disease. For a long time, oral microbes had been indiscriminately regarded
as pathogens. In fact, their removal from the oral cavity has become the main objective of
dentists. Not until recently, did we realize that like microbes associated with other parts of the
human body, most of the oral microorganisms are commensal and might have protective role
in preventing the colonization of pathogens.2,3 More importantly, increasing evidence suggests
that oral infectious diseases such as dental caries and periodontitis are often the result of the disturbed host homeostasis, and an imbalanced oral microbial ecology often leads to overgrowth
of otherwise low abundant opportunistic pathogens.4,5
Recent advances in molecular biological techniques are broadening our understanding
of bacterial diversity and the societal community interactions which occur between species in
the oral cavity.6 This has led to tremendous advances in our understanding of oral microbiology
and its involvement in health and disease, including tooth decay, gum diseases, as well as the
diseases associated with artificial dental apparatus introduced through modern dentistry.6,7
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ADVANCING UNDERSTANDING OF ORAL MICROBIOLOGY
THROUGH MOLECULAR BIOLOGICAL APPROACHES

Our bodies are home to a multitude of microbial organisms that form distinct microflora inhabiting the gut, skin,
vagina and oral cavity. These microbial communities have been
of great interest to scientists in recent years due to their impact
on host health and disease. Increasing lines of evidence indicate
that these commensal microbiotas have important metabolic,
trophic, and protective functions and greatly affect the host’s
physiology and pathology.8,9 For example, the importance of the
gut flora in digesting unutilized substrates, training the immune
system and protecting against epithelial cell injury is well appreciated,10-12 and we are beginning to understand its potential role
in systemic diseases, such as inflammatory bowel disease13,14 and
obesity.15
Molecular biological tools have been critically important for identifying the diversity of these host-associated microbiotas, including the oral microbial community.16 Prior to the
availability of such tools, determining the diversity of complex
microbiological communities, such as those of the oral microbiota had been essentially dependent on the ability to culture
and identify individual organisms. However, we then realized
that only a small fraction of the organisms comprising these
microbial communities has been isolated.6 In fact, accumulating lines of evidence suggested that there are extensive physical
and metabolic interactions between different microbial species
within the same community, which are essential for the growth
and persistence of certain microbes17 and make them recalcitrant
to cultivation. The power of molecular biological approaches,
such as culture-independent 16S rRNA gene sequencing-based
methods allows us to identify yet-uncultivable species and provides a more comprehensive and detailed inventory of human
oral microbiota.6
The studies using culture-independent approaches have
revealed the sheer magnitude of the diverse microbes, including yet-uncultivable species residing within the oral cavity.18,19
The human mouth is estimated to harbor more than 700 different bacterial species, comprising one of the most complex microbial flora.18 The diversity of microorganisms that inhabit the
oral cavity includes bacteria, archaea, protozoa and fungi.20,21
An interesting perspective regarding diversity of the oral flora
is the presence of Archaea as a constituent.22 Phylogenetically,
Archaea is among the oldest known type of prokaryotes; it has
previously been isolated from ocean bottom, and yet also appears to be a colonizer of the human oral cavity with yet-to-bedetermined role in oral microbial ecology.23 The diversity of the
microbial flora reflects tremendous genetic information and immense bio-physiological potential that may have huge impact on
host health and disease. If we consider that an average bacterial
species has 2,000-6,000 genes, then an oral bacterial population
of some 700 individual species represents a pool of over 1 million genes, 10 times more than human host genes. This provides
the oral microbial environment with a huge quantity of informa-
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tion related to unique metabolic pathways, the generation and
secretion of various factors that can control and modify their
ecological niche, and factors that may impact function of the
human host.
THE STRUCTURE OF DENTAL AND DENTURE PLAQUE

Bacteria in the oral cavity often reside within biofilms,
such as those that form dental and gingival plaque.24 For edentulous and partially edentulous individuals who wear dentures, a
denture-associated biofilm, or denture plaque, forms on the denture surface and could potentially serve as a reservoir of pathogenic microbes for infections.7
Dental and denture plaque are not simple matrices.
They consist of a diverse collection of microbial species, and
furthermore have a highly organized structure in which different
species can occupy specific sites or niches within the biofilms.25
During dental biofilm formation, bacteria that are early colonizers, such as Streptococci (i.e., S. gordonii, S. oralis, etc.) with
specific adhesins can effectively bind to proteins deposited as a
pellicle coat on the tooth surface. This is followed by the subsequent recruitment of intermediate and late colonizing species
through cell-cell coadhesion via specific adhesin-receptor interactions.25 These specific bacterial physical associations eventually generate a highly structured microbial community, which
we recognize as dental plaque or biofilms.5,6,26 Furthermore, bacterial species within dental biofilm are often engaged in extensive signaling and metabolic interactions to ensure their survival
within the microbial community.6
Dental biofilms of healthy subjects harbor a commensal
oral microbial community with properties that limit the invasive
potential of opportunistic pathogens.3,27 And likemost ecological
communities, once established, dental biofilm generally has a
stable and controlled population of different organisms and displays resilience to environmental disturbance.28,29 However, as
will be discussed in the following section, the microbial composition of denture biofilm flora and their pathogenic potentials
could differ significantly from that of healthy dental biofilm,
thus contributing to the pathogenesis of denture-biofilm related
diseases, such as stomatitis.
CONNECTIONS BETWEEN MICROBES AND ORAL DISEASES
ASSOCIATED WITH DENTURE WEARING

Denture stomatitis is a common disorder in subjects
wearing dentures, which are prostheses that provide important
functional and esthetic improvements for edentulous and partially edentulous patients.30,31 The disorder is characterized as
inflammation and erythema of the oral mucosal areas covered
by the denture. The current view regarding the etiology of denture stomatitis is that it is a multifactorial infectious disease.
It involves a number of associative factors, including dentureinduced trauma, continual denture wearing and denture plaque
harboring pathogenic microbes, such as Candida.30 Among those
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factors, the microbial biofilm formed on the denture surface
plays a significant role in contributing to the disease pathogenic
process. Whereas the normal commensal oral microbial community could prevent infection by interfering with the invasive
potential of opportunistic pathogens, this is altered in the denture
biofilm. Indeed, the microbial composition of the biofilm which
forms on denture surfaces differs significantly from that observed in the oral cavity of healthy individuals.32,33 This could be
due to the fact that denture wearing can alter normal oral physiology by affecting normal salivary flow that plays an important
role in shaping the microbial community.34 Meanwhile, the older
segment of the population often has a comparable higher proportion of denture wearer.35 These individuals are more likely
to have systemic health conditions and could have already had
imbalanced oral microbial ecosystem due to disturbance in host
homeostasis. Furthermore, a denture provides a unique abiotic
surface for microbial colonization, which often leads to the development of a denture biofilm with microbial composition and
structure different from normal oral biofilm.7,32
Compared to the normal oral and dental biofilms, denture biofilmsare associated with a much higher occurrence of
Candida yeasts, particularly Candida albicans.36 C. albicans is a
commensal fungal species commonly colonizing human mucosal surfaces. It co-exists with diverse oral microbial species and
has long been adapted to the human host.37 In healthy individuals, C. albicans is usually a minor component of their oral microfloras. However, under conditions of immune dysfunction or
local predisposing factors such as poor oral hygiene or ill-fitted
dentures, colonizing C. albicans can become an opportunistic
pathogen. In these patients, C. albicans becomes more predominant and invasive, causing recurrent mucosal infections such as
denture stomatitis.38 The presence of C. albicans on denture and
oral mucosal surfaces of denture wearers is positively associated
with denture stomatitis.39 The virulence factors of C. albicans
have been well documented.40 Among them, multiple host recognition biomolecules, such as Als1p and Hwp1p,41,42 as well
as the secreted enzymes, including Aspartyl proteinases (SAP)43
and Phospholipase (PL)44 have been shown to play important
role in determining C. albicans’ pathogenicity. Meanwhile, its
polymorphic growth patterns40 as well as phenotypic switching45
have also been implicated in contributing to its virulence. While
C. albicans infection cannot be claimed as the single causal
pathogen for inducing denture stomatitis, it has a strong associative presence when the disorder occurs, and its eradication from
denture and mucosal surfaces is associated with reversal of the
condition.46,47 Hence, it is generally accepted that C. albicans is
a main opportunistic pathogen which is involved in the development and pathogenesis of denture stomatitis. Meanwhile, certain bacterial species, such as Prevotellasp., Veillonellasp. and
Staphylococcus sp. have been found to be enriched in denture
biofilms,48,49 although their potential role in denture stomatitis
pathogenesis remains to be determined. More importantly, increasing lines of evidence indicate the extensive Candida-bacterial interactions, which could impact their pathogenicity.37 For
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example, co-infection of C. albicans and Staphylococcus aureus
has been shown to lead to increased mortality in animal model.50
A better understanding of the physiology of Candida and bacteria co-existence and the inter-kingdom Candida-bacterial interactions would shed light on the impact of polymicrobial infection on the etiology of denture-related stomatitis.
TREATMENT OF DENTURE-RELATED INFECTIOUS DISEASE

Plaque formed on the denture surface often serves as a
reservoir of opportunistic pathogens, including C. albicans for
infections. In addition to maintaining good general oral hygiene,
the most recommended approach to managing and preventing
microbial-related disease associated with denture use is for patients to maintain a high level of denture hygiene by appropriate
cleaning.51,52 Common approaches to denture cleaning utilized
by patients include brushing with abrasive cleansers, such as
toothpastes, and washing or soaking dentures using commercial
chemical cleansers with antimicrobial compounds designed for
this purpose. The latter is preferred, as brushing with abrasive
cleansers has been shown to be less effective for removal of the
biofilm, and furthermore, can roughen the denture surfaces and
result in more rapid bacterial adherence and biofilm growth.7,53
However, as observed with other biofilms, a problematic issue
associated with denture plaque is that it reduces the effectiveness of antimicrobial, including antifungal treatment.54 The
mechanisms by which biofilm environments enhance antimicrobial resistance are not fully understood. However, putative
mechanisms likely include decreased ability of the antimicrobial
agents to penetrate and diffuse within the biofilm matrix, protective functions conferred to the putatively susceptible bacteria
due to slower growth rates and even changes in phenotype, and
perhaps protective factors secreted by other microbes within the
biofilm community which can degrade the applied antimicrobial agents.55 In addition, the materials used in the manufacture
of dentures can also affect adherence and colonization by microbes, including C. albicans, as well as impact the efficacy of
antimicrobial treatment on thebiofilm.56
Soaking dentures in an appropriate commercial cleanser has been shown to be effective in removing attached microbes
without increasing surface roughness.57 Overnight denture removal is also important for controlling denture plaque, as it isolates the denture from salivary secretion that provides nutrients
for microbial growth of denture biofilm. In addition to maintaining denture hygiene, various antimicrobials, including imidazole (clotrimazole, ketaconazole), triazole (fluconazole, itraconazole) and polyene (nystatin, amphotericin B) antifungals for
treating Candida, and antibiotics for treating bacterial pathogens
were also recommended for controlling denture-related mucosal
infections.58,59
More recently, a new antifungal therapeutic approach
Photodynamic (PDT) therapy has been used to treat denture stomatitis.60 PDT uses a photosensitizing agent and light of appro-
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priate wavelength. The interaction between the photosensitizer
and light in the presence of oxygen produces reactive species
that induce cell damage and death.61 In a recent clinical trial,
PDT was shown to be as effective as topical nystatin in the
treatment of denture stomatitis.62 Since PDT can effectively kill
Candida species, including strains resistant to conventional antifungal agents,63 it has been regarded as a promising method
for the treatment of dental stomatitis. Recurrence of stomatitis
is frequently observed within short period of time after stopping antifungal treatment.64 This is likely due to reinfection by
residual pathogens that remain within plaque on dentures and
are resistant to treatment. Meanwhile, many patients failed to
respond to the usual treatment, largely due to the development
of drug resistance of candida species. For patients with systemic
diseases, such as type 2 diabetes mellitus or being immunocompromised,65 they often show less responsiveness to the treatment
as well. When treating these patients, combined efforts including
antifungal treatment and improving patients overall health status
are critical in determining the outcome.66
The knowledge we are gaining from molecular biological studies of dental and denture biofilms is contributing to the
development of novel therapeutic tools.6,67 One approach is to
build on our ability to identify specific pathogenic organisms
that inhabit the biofilm, and develop therapeutics that specifically target these organisms. An example of this approach undertaken by our research group is the development of STAMPs
(Specifically Targeted Antimicrobial Peptides).68,69 A typical
STAMP consists of two functional moieties conjoined in a linear
peptide sequence: a nonspecific antimicrobial peptide serves as
the killing moiety, whereas a species-specific binding peptide
provides specific binding to a selected pathogen and facilitates
the targeted delivery of the attached antimicrobial peptide. The
feasibility of this approach has been demonstrated by the development of C16G2, a STAMP specifically targeting S.mutans, the
bacterium known to cause dental caries. C16G2 has been shown
to remove S. mutans within in vitro multi-species biofilms with
high efficacy and specificity,68,70 and is under further animal and
human evaluations.71 The successful demonstration of this targeted approach could serve as proof-of-concept for applying this
technology to the treatment of denture-related Candida infections.
CONCLUSIONS

The past decade has witnessed significant advances in
our understanding of oral microbiota. We now better understand
the structural and functional complexity of dental and denture
plaque, and a strong connection between oral microbial ecology and host health and disease has been established. It is well
known that the control of microbial pathogens, such C. albicans
on dentures and in the oral cavity is critical for the oral health
of denture wearers. Continued efforts using modern scientific
methods will help us develop more diagnostic tools and therapeutic interventions for the identification, treatment and prevention of denture infections. New and improved approaches will
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be able to treat and control denture infections with less physical
damage to denture surfaces by providing improved mechanisms
for killing and removing microorganisms in the denture biofilm.
We can envisage products that will have targeted killing of selective pathogens without affecting other commensal species
within the same denture biofilm. Finally, we can also expect to
see new products that will be able to enhance natural oral immunity, and provide cavity protection or control gingival disease in
dentate individuals, and other inflammatory disorders in denture
wearers.
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